+454.2%
MRNA vs GLDM
+20.1%
+434.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GLDM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | +0.9% | -4.3% | -4.7% |
| 7D | -10.1% | +0.2% | -10.2% | -10.4% |
| 30D | +126.7% | +0.3% | +126.5% | +130.8% |
| 3M | +184.1% | +3.3% | +180.8% | +182.9% |
| 6M | +143.3% | -14.5% | +157.8% | +169.3% |
| YTD | +359.9% | +1.9% | +357.9% | +365.0% |
| 1Y | +454.2% | +21.1% | +433.1% | +440.5% |
| All | +454.2% | +20.1% | +434.1% | +440.5% |
Cumulative growth
Daily Returns
Daily percentage return beside GLDM.
Daily Out/Under-Performance
Portfolio return minus GLDM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GLDM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GLDM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling